XIAOBIN YU to Cell Line, Tumor
This is a "connection" page, showing publications XIAOBIN YU has written about Cell Line, Tumor.
Connection Strength
0.102
-
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents. Endocr Relat Cancer. 2021 08 13; 28(10):657-670.
Score: 0.029
-
Cell lineage tracing links ERa loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
Score: 0.028
-
The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERa and enhancing enhancer-promoter interactions. J Biol Chem. 2019 12 20; 294(51):19667-19682.
Score: 0.026
-
Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation. Int J Biol Sci. 2015; 11(5):618-28.
Score: 0.019